Search

News: LyseNTech, a Korean phage company led by Heejoon Myung, was named a leading research institute by the Korean Ministry of Trade, Industry and Energy. LyseNTech aims to develop 'LNT103', a phage-derived endolysin, as an inhaled treatmen

Paper: Evading while invading: induction of CRISPR-Cas by mucin as a mean to escape phages adhered to mucus.

Paper: Bacteriostatic effects of phage F23s1 and its endolysin on Vibrio parahaemolyticus.

Pre-print: The defence island repertoire of the Escherichia coli pan-genome.

Pre-print: Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny.

This week Madhav Madurantakam Royam, a PhD student at the University of Warwick, talks to Dr. Alexander Sulakvelidze, founder and CEO of Intralytix, one of the first modern phage companies to have products on the market. This week Madhav Ma

PHAGE Journal is celebrating the 130th birthday of George Eliava with a focused issue of phage therapy then and now — just released! Phage Therapy: Insights from the Past, the Great Need of the Present, and Glimpses into the Future A snea

Paper: Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome.

Paper: Effect of freeze drying, spray drying and electrospraying on the morphological, thermal, and structural properties of powders containing phage Felix O1 and activity of phage Felix O1 during storage.

Paper: Widespread phages of endosymbionts: Phage WO genomics and the proposed taxonomic classification of Symbioviridae.

Paper: Bacteriophage-mediated perturbation of defined bacterial communities in an in vitro model of the human gut.

Review: Novel antimicrobial agents for combating antibiotic-resistant bacteria.

Postbaccalaureate fellow: The Stibitz lab at the FDA (Silver Spring, MD) is recruiting a postbaccalaureate fellow to characterize and engineer the lytic activity of Lactic acid bacteria bacteriophage endolysins.

Lecturer: University of Toronto is seeking a Sessional Microbiology Lecturer to teach in-depth discussion of bacterial structure and ultrastructure; physiology and nutrition; growth and cultivation; nature of viruses (bacteriophage and a li

INCATE, the Incubator for Antibacterial Therapies in Europe, INCATE brings together translational and basic research, industry, experienced entrepreneurs and investors to accelerate your innovation. We do this by providing advice, community

I was wondering if anyone has a library (small or large) of Campylobacter phages and willing to share. If yes, please contact me at jyot.antani@yale.edu.

Baylor College of Medicine is putting out a reverse phage alert. If you need phage for patients we have some purified, USP certified, sequenced and endotoxin quantified ready for use! - 2 phage cocktails for E. coli - 1 phage cocktail for

The Targeting Infectious Diseases Committee is hosting the 6th World Conference on Targeting Phage & Antibiotic Resistance November 24-25 2022 in Paris, France & online. The 2-day meeting will gather leading experts from around the world t

This week, we highlight the feature articles we published in June! Learn about what happened when the Phage Australia team shipped a phage around the country, Jean-Paul Pirnay's views on phage therapy, and how producing phages has changed o

As we look forward to the 2022 Phage Futures Europe event, 6-7 July in Amsterdam, take a look at the 2021 post-event report, created in collaboration with PhD students from Phage Directory, Sheetal Patpatia and Aël Hardy, to gain insight in